by Associated Press Published: January 19,2012
Tags: courts, drugs, federal government, health, healthcare, healthcare benefits, law enforcement, lawsuit, medicine, pharmaceuticals, settlement, state government
JACKSON — Attorney General Jim Hood has asked the federal government to give him until Jan. 30 to file documents supporting Mississippi’s effort to keep $17 million from a settlement with pharmaceutical companies accused of inflating wholesale prices.
Alper Ozinal, spokesman for the federal Centers for Medicare and Medicaid Services, tells the Clarion-Ledger the agency had [...] [...]
by Associated Press Published: January 9,2012
Tags: courts, doctors, drugs, health, healthcare, illegal drugs, medicine, pharmaceuticals, physicians, prescriptions, sentencing, surgeons
GULFPORT — A former Gulf Coast surgeon has been sentenced to more than 11 years in prison for writing and selling illegal prescriptions.
In addition to the 135-month prison term, 43-year-old Je Song also was fined $10,000 by U.S. District Judge Sul Ozerden in Gulfport.
The Sun Herald said a co-defendant — 41-year-old Oliver “Butch” Shoemaker Jr. [...] [...]
JACKSON — The Mississippi Attorney General’s Office says it has recovered $6 million from three pharmaceutical companies that misreported the price of prescription drugs for Medicaid patients.
In a statement, Attorney General Jim Hood says agreements were reached with Par Pharmaceutical Inc. and Alpharma USPD Inc. and Purepac Pharmaceutical Co., now known as Actavis MidAtlantic, LLC, [...] [...]
SAUCIER — A former Mississippi doctor and another man are scheduled to plead guilty today to selling prescriptions for pain pills and anxiety drugs to people without a legitimate medical exam.
Authorities said Je Song, a former Stone County doctor, wrote prescriptions that ended up in the hands of people he never examined, and in some [...] [...]
JACKSON — Transcript Pharmacy has landed on the Inc. 5000 list of the fastest-growing privately owned businesses in America for the fourth year in a row.
It ranked 116 in the health industry.
“We are blessed to be trusted by so many healthcare professionals and so many patients who, month after month, give us the opportunity to [...] [...]
MADISON — Hawthorn Pharmaceuticals Inc. has struck an exclusive global licensing deal with CoPlex Therapeutics on hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer’s and other neurodegenerative diseases.
Under the terms of the agreement, Hawthorn will receive an exclusive worldwide license to develop and commercialize hawAD14 and will be responsible for funding [...] [...]
JACKSON — Mississippi Attorney General Jim Hood says the state has been awarded $38.2 million in a Medicaid drug-pricing lawsuit.
Hood says a judge found that a pharmaceutical company, Sandoz Inc., inflated the average wholesale prices for its generic drugs.
In a news release yesterday, Hood says the inflated number caused Mississippi Medicaid to lose money by [...] [...]
OLIVE BRANCH — Officials from Anda Distribution, a leading distributor of generic pharmaceuticals within the U.S., is locating warehousing and distribution operations in Olive Branch.
The company is constructing a new 234,000-square-foot facility in the Crossroads Distribution Center that is projected to be operational by the second quarter of 2012.
The project represents an approximately $23-million investment [...] [...]
by MBJ Staff Published: August 3,2011
Tags: construction, donations, drugs, education, fundraising, grants, higher education, medicine, pharmaceuticals, pharmacy
JACKSON — Gifts to the “Promises to Keep” campaign and two federal grants have provided the University of Mississippi School of Pharmacy with more than $10 million to construct a building at the university’s Medical Center and endow scholarships and faculty support.
The campaign’s lead gift was a pledge of more than $350,000 from Medical Marketing [...] [...]
JACKSON — A federal lawsuit filed this week in Mississippi claims a major pharmaceutical company made millions of dollars by misrepresenting clinical data and using sham litigation to maintain a monopoly over a drug used to treat depression and anxiety.
Uniondale Chemists Inc., a retail pharmacy in Uniondale, N.Y., filed the lawsuit Tuesday in U.S. District [...] [...]
Loading ...